Download as pdf or txt
Download as pdf or txt
You are on page 1of 17

4/26/2011

Complaints, MDRs, Reports of Removals


& Corrections, and Recalls
April 28, 2011

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 1

What will you learn?

• why move to eMDR’s


• what is eMDR
• the eMDR system overview and process
• what options do I have (low \ high volume)
• steps for approval
• lessons learned
• where do I go to learn more

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 2

1
4/26/2011

MDR’s Reported

350,000

300,000

250,000

200,000 2006
2008
150,000 2009
2010
100,000

50,000

0
MDR's Reported by year

• Focus on Mandatory Reports • Number of MDR’s are increasing

• 2010 numbers based on Kathleen Cummings Food and Drug Law Webinar
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 3

The way it is for Manufacturers

Mandatory MedWatch fillable PDF


Form or solution generated

Manufacturer
Manufacturer’s mail, overnight, Burn
CD’s and express MDR’s to the FDA.

Did the FDA get Do they need


It in time? something else?
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 4

2
4/26/2011

The way it is for the FDA

Attachments

Mandatory MedWatch
MAUDE

FDA receives report and has


Summary Reports
contractors type Data into
MAUDE database

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 5

FDA eMDR Goals

• Eliminate human error for data entry


• Reduce non-value added costs
• Receive accurate and timely information
• Analyze and Trend on elements in Adverse
Event Reports

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 6

3
4/26/2011

Federal Register August 21,2009

• Rules
– Proposed Rule
• Medical Device Reporting: Electronic Submission
Requirements , 42203–42217 [E9–19683]
• http://edocket.access.gpo.gov/2009/pdf/E9-19683.pdf

• Notices
– Draft Guidance for Industry, User Facilities, and Food and
Drug Administration Staff: eMDR Electronic Medical Device
Reporting; Availability , 42310 [E9–19681]
• http://edocket.access.gpo.gov/2009/pdf/E9-19681.pdf

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 7

What is eMDR?

eMDR stands for electronic Medical Device Reporting.


The eMDR project allows for electronic receipt and
processing of medical device adverse event reports to
CDRH, through the following processes:

• 1. ) Build &Transform Data: generate MedWatch data file (xml)


using HL7, ICSR Release 1message format that is mapped to the
3500A.

• 2.) Transmit the Information: The file will be transmitted


electronically to the FDA’s Electronic Gateway called (FDA ESG)
where it will automatically “load” the MedWatch file into the
FDA’s databases.
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 8

4
4/26/2011

What reports are part of eMDR?

• Manufacturer’s Mandatory MedWatch Report


• Importer and User Facility Report MedWatch Report
• MedWatch Reports with attachments as part of the
electronic file
• Follow-Up\Supplemental MedWatch Reports
• Batch reporting on the above types of MedWatch
Reports

• CDRH eMDR Phase 1 does not include:


• Alternative Summary Reporting

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 9

Definitions

Definitions to navigate through eMDR

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 10

5
4/26/2011

Definitions to navigate eMDR

FDA ESG (FDA Electronic Submission Gateway)


• FDA Electronic Submissions Gateway is an FDA agency-
wide entry point for all electronic submissions; it is an
electronic portal that routes submissions to the
appropriate FDA Center. This is the single point of entry
for the receipt and processing of all electronic
submissions in a highly secure environment that
complies with secure messaging standards.
• CHDC (Contractor Hosted Data Center) is a new data
center for the FDA ESG

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 11

Definitions to navigate eMDR

Digital Certificate
• This is a two-part electronic key, that when matched
together defines who you are as the company or
submitter. You have to have a digital certificate if you
submit through Web Trader or through your B2B
mechanism.
– Must be X.509 V3 compliant
– List of vendors at the FDA ESG website

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 12

6
4/26/2011

Definitions to navigate eMDR

Letter of Non-Repudiation
– A letter of Non-Repudiation Agreement must be
submitted to the FDA. The non-repudiation
agreement allows the FDA to receive electronically
signed submissions in compliance with 21 Code of
Federal Regulations (CFR) Part 11.100.
– Sample letters are on the FDA ESG website.

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 13

FDA eSubmitter

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 14

7
4/26/2011

Web Trader

• Log into Web Trader


• Select the FDA center: CDRH
• Browse to select your eSub zipped file
• Select Adverse Events
• Browse to select your half of the digital
Certificate, private key

15
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 15

Definitions to navigate eMDR

MAUDE
• Manufacturer and User Facility Device Experience
Database.
• MedWatch reports are submitted to the MAUDE
database for analysis by the FDA.

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 16

8
4/26/2011

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 17

eMDR Process – Step 1

• Build & Transform the Data: enter your MedWatch information into an
application and generate MedWatch data file.
• What the application has to use?
• HL7 standard (ANSI accredited standards organization)
• ICSR Release 1– Individual Case Safety Report messaging format, mapped to
the 3500A
• Utilizing codes defined by National Cancer Institute (NCI) and unique FDA
codes
1) Enter (build) your MedWatch information

2) Transform data into an xml file

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 18

9
4/26/2011

eMDR Process – Step 2

• Transmit the Information: The file will be transmitted electronically to the


FDA’s Electronic Gateway called (FDA ESG) where it will automatically “load”
the MedWatch file into the FDA’s database.
• What you have to use?
• Connector to FDA ESG Portal
• AS2 protocol
• NOT EMAIL

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 19

FDA ESG Overview

Inbound Submission (1)

Acknowledgement #1 (2) Centers

eMDR file
FDA Gateway
Industry Server
Partners
Acknowledgement #2 (4) Transfer Submission (3)

CDRH Load to eMDR (5)


ACK’s
Acknowledgement #3 (6)

1. Manufacturer sends eMDR single or batch files to FDA Electronic Submissions Gateway (ESG) using either Web Trader
or AS2 compatible transport mechanism.
2. FDA ESG server receives an inbound submission, checks digital certificate for authentication and sends
Acknowledgment 1 to the submitter. This confirms that the submission was successfully received by the FDA ESG.
3. The submission is automatically transferred to the appropriate FDA Center, specifically CDRH.
4. Acknowledgment 2 is sent by FDA ESG to the submitter to indicate that the submission has been sent to CDRH.
5. The Center validates and processes the submission.
6. Acknowledgment 3 is sent to the submitter to indicate if submission is successfully loaded into the Adverse Event
database or note any errors that occurred during validation and loading.

* Source CDRH Implementation Guide for eMDR


4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 20

10
4/26/2011

Acknowledgment 1 Acknowledgement Examples

E
S
G

Acknowledgment 2

E
S
G

Acknowledgment 3

C
D
R
H
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 21

How to build/transform your eMDR file?

– Low Volume: FDA eSubmitter – free downloadable software

Step 1

FDA eSubmitter XML file

3500A MedWatch in
COTS
eMDR submission format
ICSR Release 1 message

Data “transformed”

- High Volume: a) Commercial Off the Shelf Software b) Internally built solutions
c) middleware solutions that “Transform” data.

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 22

11
4/26/2011

Step 1 Decision Chart

Use Paper Based


NO Do you have Complaint Management
system as source System Software Solution ?
for eSubmitter
entry
YES

Use Software NO Does your System allow you generate a


system as source MedWatch report for you?
for eSubmitter
entry
YES
Does your System have ability to transform your YES Upgrade, separate
data into eMDR HL7 compliant file? install, etc

NO
Use Software
system as source
NO Does your IT group have ability to transform your YES
Middleware, etc
for eSubmitter data into an eMDR HL7 compliant file?
entry

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 23

How to transmit the eMDR file?

– Low Volume (manual solution)


• Web Trader – free connector for electronic file submission to the FDA ESG

- High Volume (automated solution)


Deploy an AS2 compatible transport mechanism that can connect to the
FDA ESG (i.e., B2B)
Step 2
Web Trader
Step 1

XML file

- OR -

3500A MedWatch in FDA ESG Gateway


eMDR submission format

B2B

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 24

12
4/26/2011

Step 2 Decision Chart


WebTrader (AS2) B2B (AS2)

YES Leverage existing


Does your company have a B2B in place?
B2B
NO
Do you have a sister division that uses a B2B?
Utilize free FDA
Currently submitting electronically to the FDA?
connector for NO Purchase or
one at a time Do you have resources to maintain a B2B? YES Leverage existing
submissions Do you have skill set to implement a B2B? B2B and
resources
Can you justify with your submission volume
Purchasing a B2B?

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 25

Options Build/Transform/Transmit
eSubmitter Step 1 Options Step 2 Options

HL7/ICSR xml file WebTrader (AS2) ACK


1
Application’s transform data
COTS

FDA
ESG

Write transformation code HL7/ICSR xml file B2B (AS2)

COTS
Custom
ACK
2

Configure transformation code


Middleware HL7/ICSR xml file CDRH/
COTS MAUDE

ACK
Custom
3

BUILD
DATA TRANSFORM TRANSMIT FDA
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 26

13
4/26/2011

Attachments

Generated
HL7 xml
Attachments (if any)

For MDR reporting the parser


that accepts the submissions
only understands two file types:
.pdf and .zip.
Submitting other types will
cause the submission’s pdf
YourFinalESubmission.zip
form or the attachments not
For eSubmitter Files
to be entered Into FDA’s
archiving system.

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 27

Steps to FDA ESG Approval

• Go to the FDA ESG website


• Follow the FDA ESG Implementation steps in the User guide
• Initially
• Determine how you are going to do your eMDR
submissions (Web Trader\AS2)
• Submit a Letter of Non-repudiation (examples at website)
• Obtain Digital certificate (see FDA ESG website)
• Register as a Trading Partner
• Send an email and then register on-line
• Signup for the test environment (Web Trader or AS2)
• Initial testing through Web Trader or your AS2 connector

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 28

14
4/26/2011

Steps to CDRH eMDR Approval

• Request your submission testing to the eMDR team


eMDR@fda.hhs.gov
• Below are six types of reports that are requested for testing. If a
particular report does not apply to your situation, please discuss
with an eMDR team
• Initial 3500A
• Initial 3500A with an attachment
• Initial 3500A followed by a supplemental 3500A (supplemental
should be submitted after initial is loaded successfully)
• Initial 3500A with section F filled out (section F is used to
provide information from user facility or importer source
report)
• Initial 3500A and source report(s) as attachments
• Batch submission that includes more than one 3500A
4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 29

Lessons Learned

• Attachments must be zipped and submitted within the xml file (except for PDF files)
• All testing has to be done with valid registration numbers for manufacturing
numbering, Importer or User Facility numbering in Section F
• Paradigm shift
Moving away from the physical form to “information”
Putting all information into the discrete data sections instead of H10/11
• Some manufacturers were struggling with internal systems to get digital certificates
for testing using the Web Trader
• Manufacturer’s IT and Functional groups have to work together to work through
the testing and plans for moving to production
• Start with the Web Trader for your initial rounds of testing and familiarity with the
entire process
• If using AS2 still utilize Web Trader as a backup
• Special characters can cause problems with generation of an xml file and the
validation as it goes to MAUDE

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 30

15
4/26/2011

eMDR Website

• Reporters should subscribe at eMDR Home Page for updates!

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 31

eMDR Contact Information

• Low Volume - eSubmitter “download and installation”


– http://www.fda.gov/ForIndustry/FDAeSubmitter/ucm108165.htm

• High Volume – HL7 Requirements


– http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Postmar
ketRequirements/ReportingAdverseEvents/ucm127951.htm

• Email Contact eMDR Project Team


– eMDR@fda.hhs.gov

• FDA Electronic Submission Gateway (FDA ESG)


– http://www.fda.gov/ForIndustry/ElectronicSubmissionsGateway/default.htm

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 32

16
4/26/2011

Thank You and Questions

4/26/2011 Copyrighted material by Pilgrim Software Inc. All Rights Reserved. This document contains confidential and/or proprietary information. Do not distribute 33

17

You might also like